C18S (p.Cys18Ser) variant of FBN2 (Fibrillin-2)

C18S (p.Cys18Ser) in FBN2 (Fibrillin-2) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.54 / 1. The record also includes population frequency data, published literature, and structural context.

C18S (p.Cys18Ser) variant details